Fig. 1.

Patient disposition for MATRIX-1 and MATRIX-2. ^aOne patient was randomized to INL-001 but not treated because of investigator decision. ^bOne patient was randomized to INL-001 but received placebo; the patient included in INL-001 mITT population and placebo safety population. ITT intent-to-treat, mITT modified intent-to-treat